GLP-1 and endometriosis: what users ask in 2026

Write down your baseline endometriosis pattern before your last GLP-1 start or dose change: pelvic pain days, bleeding pattern, bowel or bladder symptoms, and fatigue. Then track any changes with dates, not just impressions. Include common GLP-1-related GI symptoms like nausea, constipation, diarrhea, reflux, and early fullness, since these can mimic endometriosis bowel symptoms. Bring this log to your next visit so your clinician can make a clearer assessment without guessing.

Many people notice symptoms cluster around two timelines: menstrual cycle phases and medication milestones (starting or increasing a dose). Put both on the same calendar. Note whether pain or bloating spikes within the first weeks after a change versus around ovulation or bleeding. If you use an app, add tags like “dose day,” “period day,” “constipation,” and “pelvic pain” so patterns are easier to spot and share.

Constipation and slowed digestion can raise pelvic pressure and make endometriosis feel worse, even if endometriosis itself is unchanged. Log your stool frequency and form, hydration, and fiber tolerance, because “more fiber” is not helpful for everyone. Ask your pharmacist or prescriber what bowel plan is appropriate for you rather than self-treating with multiple OTC products at once. Seek prompt care if you have severe abdominal pain, vomiting, fever, blood in stool, or you cannot keep fluids down.

As of September 11, 2026, there are newer GLP-1 pills that people with endometriosis may consider for convenience, but the routines differ. Wegovy pill (oral semaglutide 25 mg) must be taken first thing in the morning with a small sip of water, at least 30 minutes before food, drinks, or other oral medicines. Foundayo (orforglipron) is a once-daily GLP-1 pill that can be taken any time of day and has no fasting or water restrictions. If you take other morning medications or supplements, ask your pharmacist or prescriber how to schedule everything safely.

GLP-1 medicines are generally not recommended during pregnancy, so it helps to talk early about pregnancy intention and timing. If you are using tirzepatide (Mounjaro or Zepbound), it can reduce oral contraceptive absorption around starts and dose increases, so your prescriber needs to know your method and your timeline. Endometriosis care often includes hormones; don’t change any hormone therapy on your own, and don’t assume a symptom change is “just the GLP-1.” Ask your OB-GYN and prescribing clinician to coordinate, especially if you are trying to conceive or managing heavy bleeding.

If cost is forcing you toward missed doses or compounded versions, tell your prescriber—adherence problems can look like symptom swings. At the time of writing, manufacturer channels and price tools may help some people compare options, including TrumpRx.gov, which lists manufacturer self-pay pathways and routes users to programs like LillyDirect or NovoCare (it is not insurance). Foundayo launched in April 2026 and has been available through LillyDirect, telehealth, and retail pharmacies, with self-pay starting at $149/month for the lowest dose and a commercial savings card as low as $25/month for eligible patients—confirm current pricing and eligibility directly with the manufacturer, your plan, or your pharmacist. If you have Medicare Part D, ask whether the temporary Medicare GLP-1 Bridge demonstration applies to you and what prior authorization criteria you meet.